Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 17/20 | 0.40 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAF1 | P04049 | 3/20 | 0.35 |
| ▸ | JAK1 | P23458 | 2/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | TYK2 | P29597 | 1/20 | 0.35 |
| ▸ | JAK3 | P52333 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31049134 | 0.93 | KRAS (0.39) | KRASMAPK3MAPK1RAF1JAK1 | |
| SCHEMBL31048892 | 0.91 | JAK1 (0.33) | KRASMAPK3MAPK1JAK1JAK2 | |
| SCHEMBL31049216 | 0.91 | KRAS (0.47) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL31049015 | 0.90 | KRAS (0.40) | KRASMAPK3MAPK1RAF1JAK1 | |
| SCHEMBL31048799 | 0.90 | KRAS (0.39) | KRASMAPK3MAPK1RAF1JAK1 | |
| SCHEMBL31048832 | 0.88 | KRAS (0.38) | KRASMAPK3MAPK1RAF1JAK1 | |
| SCHEMBL31048923 | 0.88 | KRAS (0.40) | KRASMAPK3MAPK1RAF1JAK1 | |
| SCHEMBL31049244 | 0.88 | KRAS (0.40) | KRASMAPK3MAPK1RAF1JAK1 | |
| SCHEMBL31048976 | 0.87 | KRAS (0.39) | KRASMAPK3MAPK1RAF1JAK1 | |
| SCHEMBL31048861 | 0.87 | KRAS (0.39) | KRASMAPK3MAPK1RAF1JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024167922-A2 | HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-08-15 | — | — | WO | disclosed |